Oncology Times Welcomes New Advisory Editors: Mikkael Sekeres, MD, MS Ramaswamy Govindan, MD
Source Newsroom: Wolters Kluwer Health: Lippincott Williams & Wilkins
Newswise — Oncology Times has added two Clinical Advisory Editors to its editorial team: Mikkael A. Sekeres, MD, MS, as Clinical Advisory Editor for Hematology/Oncology, and Ramaswamy Govindan, MD, as Clinical Advisory Editor for Oncology. Oncology Times is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, and pharmacy.
“We are delighted to have these two distinguished Oncologists join our editorial advisory board,” said Oncology Times Editor Serena Stockwell. “The contributions of Drs. Sekeres and Govindan will serve to help our readers stay up to date in their respective areas of expertise, ensuring that our news coverage is relevant and timely, while offering their unique perspectives.”
Oncology Times Editorial Board Chair Robert C. Young, MD, pointed to the publication’s mission of providing news, analysis, commentary, and controversy as the independent hematology/oncology news source. “We are very pleased to welcome Dr. Govindan and Dr. Sekeres to the Oncology Times team,” he said.
Dr. Sekeres is Director of the Leukemia Program at the Cleveland Clinic Taussig Cancer Institute, where he is also chair of the Hematology/Oncology Pharmacy & Therapeutics Committee. He is a staff member in the Department of Hematologic Oncology and Blood Disorders and holds a joint appointment in the Departments of Translational Hematology and Oncology Research. Dr. Sekeres is also Associate Professor of Medicine at Cleveland Clinic, having trained earlier in his career at Harvard University.
Dr. Sekeres, also a member of the FDA’s Oncologic Drugs Advisory Committee, said, “I am looking forward to collaborating with the outstanding staff at Oncology Times in bringing the latest in news and independent opinion to the hematology and oncology community.”
A member of the National Cancer Institute’s PDQ Editorial Board, he is also Co-chair of the Aplastic Anemia and MDS International Foundation’s Medical Advisory Board. He has had several leadership roles in the American Society of Hematology, has served as a peer reviewer for all the major hematology/oncology journals, has over 100 scientific publications, and has been on the Best Doctors list of Cleveland Magazine for the last three years.
Dr. Govindan, an internationally recognized expert in lung cancer, is the Director of the Thoracic Medical Oncology Program at the Alvin J. Siteman Cancer Center at Washington University School of Medicine, as well as Professor of Medicine at Washington University School of Medicine.
Dr. Govindan, who currently serves as the Editor of the American Society of Clinical Oncology’s annual Education Book and has authored, coauthored, or edited numerous papers and publications, said, “It is a real honor to work with the distinguished experts and staff at Oncology Times. Research in oncology is proceeding at a breakneck speed, and the significant advances and knowledge gleaned from bench research are being translated ever more rapidly to the bedside.” Dr. Govindan added, “I am very pleased to join Oncology Times in helping to keep the oncology community abreast of the latest developments and communicate news about the exciting world of oncology research.”
About Oncology Times
Oncology Times, the independent hematology/oncology news source for the cancer care team, is published twice a month. It is mailed to 45,000 cancer specialists, including oncologists, hematologist-oncologists, oncology nurses, and other cancer care professionals, and reports on breaking clinical news as well as the professional, political, reimbursement, and practice management issues that affect those treating cancer patients.
Lippincott Williams & Wilkins
Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.
LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer’s leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer has 2009 annual revenues of €3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.